Liquidia Corp (LQDA) Stock Price, Quote & News

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneou...

Industry: Biotechnology

Sector: Healthcare

Phone: 919 328 4400

Fax: 919 328 4402

Website: www.liquidia.com

Address:

419 Davis Drive, Suite 100, Morrisville, United States

HedgeAlerts Nov. 14 at 6:42 PM

Hedge Alert Live - Protect Your Portfolio Contract: $LQDA $27.50 Put · NOV 21, 2025 Exp Entry Price: $1.60 - $1.65 Exit Price Target: $2.69 Profit Margin: +63% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com

0 · Reply

Ms_P Nov. 14 at 3:28 PM

$CDTX $IOVA $LQDA Companies waiting for MRK may need to make a deal with another player or be prepared to go it alone. MRK does still have a way to go to make up for Keytruda patent cliff https://endpoints.news/merck-to-buy-cidara-and-its-preventive-influenza-biologic-for-9-2b/

3 · Reply

Gambaa Nov. 14 at 2:50 PM

$LQDA

0 · Reply

JFais Nov. 14 at 2:48 PM

$LQDA (L) Another chart update from my Q3 portfolio review

1 · Reply

HedgeAlerts Nov. 14 at 8:02 AM

Hedge Alert Live - Protect Your Portfolio Contract: $LQDA $25.00 Put · NOV 21, 2025 Exp Entry Price: $1.13 - $1.35 Exit Price Target: $1.56 Profit Margin: +38% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com

0 · Reply

HedgeAlerts Nov. 14 at 6:52 AM

0 · Reply

BullRun4 Nov. 13 at 2:55 PM

$LQDA $30 coming soon!!! We are days away from $30+

0 · Reply

Gambaa Nov. 13 at 2:36 PM

$LQDA They can’t keep it under $30 for long 🤑

0 · Reply

Ms_P Nov. 13 at 1:49 PM

$LQDA This reasoning does make sense to me. If it was simple that he agreed with UTHR, more likely that the decision would have been issued earlier (before more ILD patients are treated with Yutrepia)

0 · Reply

stevemano Nov. 13 at 10:10 AM

$LQDA wow ! A negative PE of 19. Hello! McFly! Anybody home?? Ultimate pimp n dump

0 · Reply

Liquidia Corporation: Heading In The Right Direction

Nov 3, 2025, 12:16 PM EST - 11 days ago

Liquidia Corporation (LQDA) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 8:00 AM EST - 12 days ago

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences

Oct 29, 2025, 2:46 PM EDT - 16 days ago

Liquidia Corporation (LQDA) Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies Transcript

Oct 27, 2025, 8:30 AM EDT - 19 days ago

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

Oct 7, 2025, 6:30 AM EDT - 5 weeks ago

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

Aug 27, 2025, 8:30 AM EDT - 2 months ago

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Aug 13, 2025, 2:51 PM EDT - 3 months ago

Liquidia Analysts Raise Their Forecasts Following Q2 Results

Aug 12, 2025, 2:25 PM EDT - 3 months ago

Why Is Liquidia Stock Trading Higher On Tuesday?

Aug 12, 2025, 12:43 PM EDT - 3 months ago

Liquidia Corporation (LQDA) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 6:30 AM EDT - 3 months ago

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jun 30, 2025, 10:40 AM EDT - 4 months ago

What Next For Liquidia After Launch?

Jun 23, 2025, 4:34 PM EDT - 5 months ago

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Jun 2, 2025, 6:30 AM EDT - 5 months ago

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

May 28, 2025, 11:08 AM EDT - 6 months ago

These Analysts Boost Their Forecasts On Liquidia

May 28, 2025, 8:00 AM EDT - 6 months ago

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

May 23, 2025, 2:28 PM EDT - 6 months ago

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

May 12, 2025, 6:00 AM EDT - 6 months ago

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

May 10, 2025, 9:29 PM EDT - 6 months ago

Liquidia Corporation (LQDA) Q1 2025 Earnings Call Transcript

May 8, 2025, 6:30 AM EDT - 6 months ago

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 5, 2025, 4:06 PM EDT - 6 months ago

Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month

May 2, 2025, 5:28 PM EDT - 7 months ago

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

May 1, 2025, 8:00 AM EDT - 7 months ago

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 30, 2025, 9:30 AM EDT - 7 months ago

Arquitos Capital's Largest Holdings For Q1 2025

Apr 1, 2025, 10:33 AM EDT - 8 months ago

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 8 months ago

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 28, 2025, 9:30 AM EDT - 8 months ago

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Mar 19, 2025, 11:56 AM EDT - 8 months ago

Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 6:30 AM EDT - 8 months ago

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 12, 2025, 8:00 AM EDT - 8 months ago

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Nov 15, 2024, 10:20 AM EST - 1 year ago

Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off

Nov 13, 2024, 2:40 PM EST - 1 year ago

Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 6:30 AM EST - 1 year ago

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 7, 2024, 10:00 AM EDT - 1 year ago

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Oct 2, 2024, 6:00 AM EDT - 1 year ago

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Oct 1, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Sep 30, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Impacted Investors Are Encouraged To Contact The Schall Law Firm

Sep 30, 2024, 8:00 AM EDT - 1 year ago

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

Sep 29, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Inquiry Into Liquidia Corporation

Sep 28, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Investors Are Invited To Contact The Schall Law Firm

Sep 24, 2024, 11:00 AM EDT - 1 year ago

Investors Are Invited To Help The Schall Law Firm Investigate Whether Liquidia Corporation Violated Securities Laws

Sep 23, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Looking Into Liquidia Corporation For Securities Fraud And Shareholders With Losses Should Reach Out

Sep 21, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation May Have Defrauded The Public And The Schall Law Firm Wants Shareholders With Losses To Reach Out

Sep 20, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Has Launched An Inquiry Into Liquidia Corporation For Violating Securities Laws And Affected Investors Should Participate

Sep 19, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Securities Fraud And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

Sep 18, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Invites Investors To Join An Inquiry Into Liquidia Corporation For Violating Securities Laws

Sep 17, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Securities Fraud And Affected Stakeholders Are Urged To Reach Out To The Schall Law Firm

HedgeAlerts Nov. 14 at 6:42 PM

0 · Reply

Ms_P Nov. 14 at 3:28 PM

3 · Reply

Gambaa Nov. 14 at 2:50 PM

$LQDA

0 · Reply

JFais Nov. 14 at 2:48 PM

$LQDA (L) Another chart update from my Q3 portfolio review

1 · Reply

HedgeAlerts Nov. 14 at 8:02 AM

0 · Reply

HedgeAlerts Nov. 14 at 6:52 AM

0 · Reply

BullRun4 Nov. 13 at 2:55 PM

$LQDA $30 coming soon!!! We are days away from $30+

0 · Reply

Gambaa Nov. 13 at 2:36 PM

$LQDA They can’t keep it under $30 for long 🤑

0 · Reply

Ms_P Nov. 13 at 1:49 PM

0 · Reply

stevemano Nov. 13 at 10:10 AM

$LQDA wow ! A negative PE of 19. Hello! McFly! Anybody home?? Ultimate pimp n dump

0 · Reply

BullRun4 Nov. 12 at 9:16 PM

$LQDA $30 coming soon!! 💰💰💰

0 · Reply

stevemano Nov. 12 at 8:33 PM

$LQDA whoops

1 · Reply

bolttup Nov. 12 at 7:09 PM

$LQDA big boys are loading up 👀

1 · Reply

Randy_Lahey_Trevor_Corey Nov. 12 at 4:38 PM

$LQDA if this hits 40 I’ll buy everyone a drink

1 · Reply

Gambaa Nov. 12 at 2:51 PM

$LQDA so cheap

1 · Reply

bolttup Nov. 11 at 5:10 PM

$LQDA Judges do not work on Veterans Day because it is a federal holiday. Big decision incoming

0 · Reply

SteelerJon Nov. 11 at 2:18 PM

$LQDA Stay positive 😎🏦🏦

0 · Reply

nomalarkey Nov. 11 at 1:56 PM

$MNKD $LQDA

1 · Reply

bolttup Nov. 11 at 3:02 AM

$LQDA “Confidence was expressed regarding the patent litigation outcome.” https://m.uk.investing.com/news/transcripts/liquidia-at-ubs-global-healthcare-strategic-growth-in-focus-93CH-4361572

0 · Reply

nomalarkey Nov. 11 at 2:06 AM

$MNKD vs $LQDA over the last 5 years including market cap. #numbersdontlie #mathiseasy #natedeflectswithwordsalad

0 · Reply

EnchantedAsparagusJr Nov. 11 at 1:07 AM

$LQDA Does patent 327 affect all marketability? Or just PH-ILD indication?

1 · Reply

victorgn Nov. 10 at 6:33 PM

$LQDA 44$ ONLY !

0 · Reply

Market Cap	2.34B
Revenue (ttm)	14.00M
Net Income (ttm)	-130.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-931.36%
Debt to Equity Ratio	8.73

Volume	2,042,000
Avg Vol	2,638,424
Day's Range	N/A - N/A
Shares Out	87.00M
Stochastic %K	75%
Beta	0.12
Analysts	Strong Sell
Price Target	$44.00